Creative Medical Technology Holdings, Inc. (NasdaqCM: CELZ)
Health Care · Biotechnology · US
$0.74
-11.63% today · -79.5% 1Y
Creative Medical Technology Holdings, Inc. (NasdaqCM: CELZ) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.89M and employs 4 people.
Over the last twelve months the share price has lost 79.5%, trading between 0.62 and 6.25.
Tweenvest scores Creative Medical Technology Holdings, Inc. across four factors: quality 45/100, value 27/100. Its strongest factor is quality.
CELZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.89M
- Revenue (TTM)
- $3.00K
- P/E
- —
- EPS
- -1.95
- Dividend yield
- —
- Beta (5Y)
- 1.90
- 52-week high
- $6.25
- 52-week low
- $0.62
- Avg volume (3M)
- —
- Shares outstanding
- 6.59M
- Employees
- 4
- Next earnings
- —
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
- ISIN
- US22529Y4089
- Listed since
- Nov 6, 2015
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AIM ImmunoTech Inc.NYSEAM: AIM | $5.12M | $0.17 | -6.61% |
| Plant Advanced Technologies SAENXTPA: ALPAT | $5.01M | €3.98 | +1.02% |
| Cardio Diagnostics Holdings, Inc.NasdaqCM: CDIO | $5.00M | $1.69 | -9.63% |
| genXone S.A.WSE: GX1 | $4.90M | zł5.76 | -2.37% |
| bioAffinity Technologies, Inc.NasdaqCM: BIAF | $4.79M | $3.73 | -21.06% |
| Stem Cells Spin S.A.WSE: SCS | $4.68M | zł0.44 | -10.20% |
| AFC Agro Biotech LimitedDSE: AFCAGRO | $4.67M | Tk5.00 | -12.28% |
| Xenetic Biosciences, Inc.NasdaqCM: XBIO | $4.66M | $1.99 | -6.57% |
Figures last refreshed Oct 18, 2026.